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Abstract 36 
Aim: The horse joint, due to its similarity with the human joint, is the ultimate model for 37 
translational articular cartilage repair studies. This study was designed to determine the 38 
critical size of cartilage defects in the equine carpus and serve as a benchmark for the 39 
evaluation of new cartilage treatment options.  40 
Materials and Methods: Circular full-thickness cartilage defects with a diameter of 2, 4 and 8 41 
mm were created in the left middle carpal joint and similar osteochondral (3.5 mm in depth) 42 
defects in the right middle carpal joint of five horses. Spontaneously formed repair tissue was 43 
examined macroscopically, with MR and µCT imaging, polarized light microscopy, standard 44 
histology and immunohistochemistry at 12 months.  45 
Results: Filling of 2 mm chondral defects was good (77.8±8.5%) but proteoglycan depletion 46 
was evident in Safranin-O staining and gadolinium-enhanced MRI (T1Gd). Larger chondral 47 
defects showed poor filling (50.6±2.7% in 4 mm and 31.9±7.3% in 8 mm defects). Lesion 48 
filling in 2, 4 and 8 mm osteochondral defects was 82.3±3.0%, 68.0±4.6% and 70.8±15.4%, 49 
respectively. Type II collagen staining was seen in 9/15 osteochondral defects but only in 50 
1/15 chondral defects. Subchondral bone pathologies were evident in 14/15 osteochondral 51 
samples but only in 5/15 chondral samples. Although osteochondral lesions showed better 52 
neotissue quality than chondral lesions, the overall repair was deemed unsatisfactory because 53 
of the subchondral bone pathologies.  54 
Conclusions: We recommend classifying 4 mm as critical osteochondral lesion size and 2 mm 55 
as critical chondral lesion size for cartilage repair research in the equine carpal joint model. 56 
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Introduction 59 
Animal models are used for the evaluation of the efficacy of new surgical techniques. When 60 
investigating articular cartilage repair in vivo, joint size and cartilage thickness are considered 61 
key factors in defining the most appropriate species. (1,2) The joint size, cartilage thickness 62 
and gait mechanics of the horse are closest to those of humans. (3,4) Moreover, naturally 63 
occurring equine cartilage lesions have similar etiology as human lesions. (1,3,4) These 64 
similarities allow for a realistic evaluation of novel methods for cartilage repair. In the equine 65 
model, stifle, tarsotibial and carpal joints have been used in translational cartilage repair 66 
research. To enable effective use of the equine model in translational cartilage research, the 67 
intrinsic repair capacity of equine cartilage in the specific joint must be known. 68 
A critical-sized lesion is a lesion of a size beyond which the defect does not heal 69 
spontaneously. Knowledge about critical lesion sizes in animal experiments is necessary for 70 
cost reduction and minimizing the suffering of animals while still providing reliable data on 71 
the effect of the studied technique. Critical lesion size used in previous equine studies has 72 
been defined as lesion size beyond which any void made is not filled. (5) However, tissue 73 
quality should also be taken into consideration when defining cartilage repair. Aiming at 74 
tissue regeneration, i.e. restoration of normal tissue architecture and function, instead of 75 
merely filling the defects is paramount for achieving durable results. (6) Therefore, this kind 76 
of defect filling cannot be considered to be successful healing.  77 
There are no recent studies on spontaneous cartilage repair in the equine carpus, and previous 78 
studies have generally used basic methods, such as macroscopic inspection, standard 79 
histology and basic biochemistry for the assessment of repair tissue quantity and quality. (5,7) 80 
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Apart from this, to our knowledge, there are no data on the long-term evolution of artificially 81 
made superficial chondral lesions in horses. Given the increasing recognition of the equine 82 
model for the evaluation of cartilage repair techniques, (1,3,8) and the equine carpus being the 83 
most common site of naturally occurring osteoarthritis after metacarpophalangeal joint, (9) 84 
our study focused on characterization of the long-term spontaneous repair of variably sized 85 
chondral and osteochondral defects in the equine carpus using state-of-the-art analytical 86 
techniques. As small cartilage defects have been thought to heal well, (3,5,8) we hypothesized 87 
that the critical defect size would be larger than 2 mm in diameter. The information obtained 88 
in this study can be used as a benchmark when evaluating the effect of different techniques 89 
aiming at cartilage regeneration in an equine translational model, as it defines to what extent 90 
lesions of different sizes will heal spontaneously over a long period (12 months) in the equine 91 
carpus.  92 
 93 
Methods 94 
Surgical procedure 95 
Five 24-month-old horses (Equus caballus) were included in this study. The study was 96 
authorized by the Utrecht University Animal Experiments Committee (0412.0601, Utrecht, 97 
The Netherlands) in compliance with the Dutch Act on Animal Experimentation. The animal 98 
care was in accordance with Utrecht University guidelines. Surgery was performed under 99 
general anesthesia following routine clinical procedures. All the horses were assessed 100 
clinically and radiologically prior to inclusion in the study and were found to be skeletally 101 
mature and to present no abnormalities.  102 
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The horses received meloxicam pre-operatively (0.6 mg/kg, i.v., Metacam®, Boehringer 103 
Ingelheim). The middle carpal joints were approached through a lateral-dorsal and medio-104 
dorsal 1.5–2 cm length arthrotomy to create defects of 2 mm (3 mm2), 4 mm (13 mm2), 6 mm 105 
(28 mm2) and 8 mm (50 mm2) in diameter on the 2nd, 3rd and 4th carpal bones as shown in 106 
Figure 1. Defects were pre-punched with a 2, 4, 6 or 8 mm skin biopsy punch. For chondral 107 
defects, cartilage was carefully removed with ring curettes onto the level of calcified cartilage 108 
(approximately 1 mm in depth) in the left carpus. For osteochondral lesions created in the 109 
right carpus, drilling was performed under continuous lavage with Ringer’s solution using a 110 
hand drill. A 2, 4, 6 or 8 mm pointed drill bit was initially used, followed by a custom-made 111 
flattened drill bit of the same size and a custom-made drill sleeve to provide a uniform defect 112 
with a flattened bottom and controlled depth of 3.5 mm. Healthy cartilage adjacent to the 113 
lesions served as control for all defects. 114 
Post-operatively, the animals were confined to individual box-stalls (3.5×3.5m) for two 115 
weeks, after which a gradual six-week rehabilitation program consisting of incremental 116 
controlled walking started. Thereafter, depending on the season and weather conditions, the 117 
animals were turned out to pasture or kept in box stalls with daily exercise of 20-30 minutes 118 
in a mechanical horse walker. The exercise regimen was identical for all horses. Synovial 119 
fluid and blood samples were collected at weeks 0, 2, 6, 14, 26, 38 and immediately after 120 
euthanasia. The total follow-up period was 12 months during which the lesions were allowed 121 
to heal spontaneously. 122 
The 6 mm lesions created in os carpale IV were used in other studies. (10-12) As their 123 
processing was different from the other samples, the 6 mm lesions are not included in this 124 
study.  125 
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Macroscopic evaluation and sample collection 126 
After sacrificing the animals, the carpal joints were opened and macroscopic photographs 127 
were taken. Cylindrical osteochondral samples (14 mm in diameter and approximately 1 cm 128 
in depth) were taken using a hollow drill that was centered over the original lesion. The 129 
samples were frozen and stored at –20°C until further processing.  130 
Micro-computed tomography (µCT) 131 
The samples were thawed in PBS supplemented with inhibitors of metalloproteinases [5 mM 132 
ethylenediamine tetraacetic acid (EDTA) disodium salt (VWR International, Fontenay, 133 
France) and 5 mM benzamidine hydrochloride (Sigma-Aldrich, St. Louis, MO)], and 134 
analyzed with a SkyScan-1172 scanner (SkyScan, Aartselaar, Belgium). The volume of 135 
interest was a cylinder with the diameter of the defect size and height of 6 mm. In control 136 
samples, the diameter was 8 mm. The data was analyzed for the structural bone parameters: 137 
bone volume fraction (BV/TV), trabecular thickness (Tb.Th), trabecular spacing (Tb.Sp), and 138 
trabecular number (Tb.N).  139 
Magnetic resonance imaging (MRI) 140 
Thawed samples were MR imaged with a 9.4 T device (Oxford 400 NMR vertical magnet; 141 
Oxford Instruments, Witney, England), equipped with a Varian DirectDrive console (VnmrJ 142 
2.3, Varian, Palo Alto, CA, USA) and a 19 mm quadrature volume coil (RAPID Biomedical, 143 
Rimpar, Germany). The specimens were placed in a test tube and immersed in saline. T2 144 
relaxation time was measured in a single slice of 1 mm thickness using a single echo spin 145 
echo sequence with TEs of 12, 24, 50, 80 and 110 ms, a TR of 2.5 s and in-plane resolution of 146 
70 x 140 μm. Native T1 relaxation time was measured in the same slice with the same 147 
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resolution, using a progressive saturation recovery sequence with TRs of 0.3, 0.6, 1.2, 2.4 and 148 
4.8 s and TE of 11.7 ms. After the first scans, the specimens were immersed in a 1.0 mM Gd-149 
DTPA2- solution for 20 hours at room temperature (RT), after which T1Gd was measured using 150 
the same saturation recovery sequence with the same resolution, but with TRs of 0.1, 0.2, 0.4, 151 
0.8 and 1.6 s. Two regions of interest (ROIs) were defined in the MR images as exemplified 152 
in Figure 2:  ROI 1 covered exclusively any repair tissue at the lesion sites of the samples, 153 
regardless of its location (repair tissue only). ROI 2 was spatially aligned with the 154 
surrounding healthy cartilage and located where the repair tissue assumingly should be if 155 
everything was perfectly healed, and further split into superficial and deep halves (upper and 156 
lower part of the cartilage). A control ROI was defined in the adjacent healthy tissue and also 157 
split into superficial and deep halves. 158 
Polarized light microscopy 159 
After the imaging studies, the samples were processed for histology. The sample cylinders 160 
were fixed in 10% formalin for 48 hours at RT. The samples were decalcified in 10% EDTA 161 
and 4% formaldehyde in 0.1 M phosphate buffer at RT, cut in half, dehydrated in ascending 162 
alcohol series, and embedded in paraffin. Tissue sections of 5 µm in thickness were cut from 163 
the middle of the lesion.  164 
Unstained tissue sections were measured using polarized light microscopy (Leitz Ortholux II 165 
POL, Leitz Wezlar, Wezlar, Germany). (13) The repair tissue was evaluated using a 300-µm-166 
wide ROI, which was divided into ten layers of equal thicknesses for the analysis. The 167 
orientation of collagen fibrils in relation to the cartilage surface (0–90 degrees), and 168 
parallelism index (PI), which describes the randomness of fibril orientations within the pixel 169 
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(0–1, where 0 indicates completely random organization and 1 indicates completely parallel 170 
organization), (13) were determined from the most superficial, middle and the deepest 171 
section.  172 
Histological and immunohistological evaluation 173 
Tissue sections were stained with Safranin-O using standard protocols. (14) Mosaic images of 174 
the histological sections were generated with the Zeiss AxioImager Z1 microscope system 175 
equipped with an AxioCam MRc5 camera and Zen blue edition software (Carl Zeiss 176 
Microscopy GmbH).  177 
Lesion filling was calculated from the Safranin-O stained sections using color thresholding in 178 
the Fiji program. (15) The ROI from which the lesion filling was calculated covered the entire 179 
lesion, with the width being the defect diameter and the depth being 1 mm for chondral 180 
lesions and 3.5 mm for osteochondral lesions. As the ROI for the osteochondral defects 181 
extended into the subchondral bone, the natural trabecular spaces in the sections resulted in 182 
empty spaces and thus in a smaller filling degree in the healthy osteochondral control samples 183 
than in the chondral samples.  184 
The Safranin-O stained tissue sections in study III were evaluated using the OARSI 185 
histopathology score validated for equine cartilage, in which each parameter is evaluated 0–4 186 
where 0 represents healthy cartilage tissue.(16) The sections were scored by three 187 
independent, blinded observers and an average of the scores was used. The defects that lacked 188 
any repair tissue were given the worst score of 4 for each parameter. 189 
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A previously published protocol (14) was used to evaluate the staining for type I and type II 190 
collagen. Briefly, the sections were digested with hyaluronidase (2 mg/ml, Sigma-Aldrich) 191 
and pronase (2 mg/ml, Calbiochem, Merck KGaA), and immersed in hydrogen peroxide 192 
(EnVision®+ System-HRP (AEC), Dako North America Inc.) to block endogenous 193 
peroxidase activity. Non-specific staining was blocked with 10% normal goat serum (Dako 194 
Denmark A/S, Glostrup, Denmark). The sections were then incubated overnight at 4°C with 195 
primary antibodies against collagen type II (ab34712, Abcam) and collagen type I (ab34710), 196 
and diluted to 4 µg/ml with PBS supplemented with 1% bovine serum albumin (Sigma-197 
Aldrich). Horseradish peroxidase (HRP)-conjugated goat anti-rabbit secondary antibody 198 
(Dako) was then applied. Antibody binding was visualized with AEC substrate chromogen 199 
(Dako). The staining of each sample was evaluated under light microscopy.  200 
Statistical analysis 201 
Confidence intervals and standard errors were calculated with the IBM SPSS Statistics 22 202 
software. Osteochondral and chondral lesions of the same diameter were compared to each 203 
other. The significances of differences in the µCT, MRI and polarized light microscopy 204 
parameters were evaluated with a pairwise t test, and Sidak adjustment was made for multiple 205 
testing. Significances of difference in lesion filling was calculated with permutation type 206 
ANOVA testing and Sidak adjustment. Comparisons of lesions and control tissue were made 207 
with permutation type ANOVA testing with Dunnet method. A p value under 0.05 was used 208 
as the threshold to indicate a statistically significant difference. 209 
 210 
Results 211 
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Post-operative animal wellbeing 212 
The surgeries were uneventful and all animals recovered well. All the horses demonstrated a 213 
pattern of decreasing joint effusion and lameness after surgery that can be expected during the 214 
normal healing of an arthrotomy in clinical cases. Joint effusion and lameness were minimal 215 
at postoperative day 10 during suture removal and all the horses were fully recovered by 3-4 216 
weeks post-surgery. No clinical abnormalities were noticed in any of the horses during the 217 
remainder of the experiment. 218 
Gross appearance of the repair tissue 219 
Most of the 2 mm lesions showed good macroscopic filling (5 of 5 osteochondral and 3 of 5 220 
chondral defects) (Figure 3). The 4 mm lesions were clearly distinguishable from the 221 
surrounding healthy cartilage and were incompletely filled. One chondral 4 mm lesion 222 
(animal D) showed rather good filling. Each of the 8 mm lesions was incompletely filled. No 223 
degenerative changes were detected. 224 
Micro-computed tomography 225 
Visually, the bone structure was normal under the chondral lesions of 2 mm and 4 mm in 226 
diameter (Figure 4). Bone compactness was visually observed to be decreased in 4 of the 5 227 
chondral lesions with a diameter of 8 mm, and one of these samples showed a small 228 
subchondral bone erosion. There were subchondral bone changes in all but one of the 229 
osteochondral defects (the exception being horse E, 2 mm lesion). Only two osteochondral 230 
samples with a diameter of 2 mm presented without cyst-like bone changes. All osteochondral 231 
lesions of 4 mm and 8 mm in diameter had unhealed bone or a cyst-like bone lesion. There 232 
were no clear trends in the numeral µCT data and the individual variation between the 233 
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samples was large.  No statistically significant differences were found between the chondral 234 
and osteochondral defects but the trabeculae were thinner in osteochondral defects of all sizes 235 
than in healthy control tissue (p=0.003).  236 
Magnetic resonance imaging 237 
The relaxation times in ROI 1 (repair tissue only) showed no clear trends with respect to the 238 
increasing lesion diameter (Figure 5a). However, T1Gd relaxation times were shorter (p=0.014 239 
and p<0.001 for osteochondral and chondral lesions, respectively) and T1 relaxation times 240 
slightly longer (p=0.156 and p=0.037 for osteochondral and chondral lesions, respectively) in 241 
the repair tissues than in the control samples (Figure 5).   242 
In all ROIs, the osteochondral lesions had longer T1Gd relaxation times than the chondral 243 
lesions, indicative of a higher proteoglycan content. However, no statistically significant 244 
differences were observed. In ROI 1, the T2 relaxation time was shorter in the 8 mm wide 245 
osteochondral defects than in the chondral defects (33.8±0.8 ms for osteochondral and 246 
41.0±1.3 ms for chondral lesions, p=0.020). ROI 2 (lesion area aligned to adjacent healthy 247 
cartilage) showed increasing T2s with larger lesion diameters and towards the cartilage 248 
surface. Osteochondral lesions with a diameter of 8 mm deviated from this trend and showed 249 
lower T2 values (48.9±8.4 ms) than the 4 mm lesions (59.2±10.3 ms). The 8 mm lesions also 250 
demonstrated a significant difference between the osteochondral and chondral samples in the 251 
deep part of ROI 2 (103.9±12.2 ms for chondral and 48.9±8.4 ms for osteochondral defects, 252 
respectively, p=0.020).  253 
The T1 relaxation time of the chondral samples in ROI 2 showed a trend of increasing with 254 
lesion diameter and from the deep part of the tissue towards the cartilage surface (Figure 5b 255 
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and c). The T1 relaxation times of all chondral lesions were higher than those of the control 256 
tissue (p<0.001). The largest variation in T1 relaxation time was noted for osteochondral 257 
lesions with a diameter of 8 mm. T1 relaxation time did not show significant differences 258 
between the groups in either of the ROIs. 259 
Changes in the relaxation times were visually observed, especially in the T1Gd relaxation time 260 
between the lesion sites and adjacent tissue, exemplified here in the cases of the 2 mm lesions 261 
(Figure 2). While the relaxation times of the subchondral bone are not shown, also differences 262 
in the MRI signal of the subchondral bone immediately below the lesion site were observed 263 
between the lesion types: a uniform appearance of the signal is seen below the chondral 264 
lesions, while an area of increased signal was present in the vicinity of the osteochondral 265 
lesions, indicating an increased water content in the area (Figure 2). 266 
Polarized light microscopy 267 
Polarized light microscopy showed high parallelism indexes (PI) in all samples (Figure 6). 268 
Chondral lesions with a diameter of 2 mm showed a higher parallelism of collagen fibrils than 269 
osteochondral lesions in the deep part of the repair tissue (0.891±0.02 for chondral and 270 
0.787±0.03 for osteochondral lesions, p=0.042). Otherwise, no statistically significant 271 
differences in the PI between the lesion diameters or the lesion depths were detected.  272 
Collagen orientation showed large variations between the groups and between individual 273 
samples. Collagen orientation changed toward the typical tangential orientation in the 274 
superficial part of the 2 mm lesions (Figure 7a) and deviated from what was expected in the 275 
larger lesions. The osteochondral samples showed a higher level of fibril organization than the 276 
chondral samples in the deep part of the tissue, the collagen orientation being 61.6±4.3° for 4 277 
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mm and 69.5±2.7° for 8 mm osteochondral defects, and 35.4±7.0° for 4 mm and 33.6±2.2° 278 
for 8 mm chondral defects (p=0.047 and p=0.004 for 4 mm and 8 mm lesions, respectively).  279 
Histological repair quality 280 
Lesion filling was analyzed from the Safranin-O stained sections. Filling of the osteochondral 281 
control samples was 81.7±0.2% and filling of chondral controls was 99.4±4.7%. Lesion 282 
filling was most complete (82.3±3.0%) in the osteochondral lesions in which the repair tissue 283 
reached the level of the surrounding cartilage surface in all of the 2 mm lesions (Figure 7, 284 
Figure 8). On the other hand, 4 of 5 of the 4 mm lesions and 1 of 5 of the 8 mm lesions 285 
presented with repair tissue non-aligned with the surrounding cartilage with filling of 286 
68.0±4.6% for 4 mm osteochondral defects and 70.8±15.4% for 8 mm defects, respectively. 287 
All of the 2 mm chondral lesions showed good lesion filling (77.8±8.5%) whereas filling of 288 
the 4 mm chondral defects was 50.6±2.7% and filling of the 8 mm defects was 31.9±7.3%. 9 289 
of 10 of the 4 mm and 8 mm lesions showed only small islands of unstained repair tissue or 290 
even a complete absence of repair cartilage in the histological sections. Islands of repair tissue 291 
occurred at sites where the subchondral bone plate was disrupted (Figure 8). None of the 292 
defects showed lateral expansion. The filling of osteochondral samples did not differ from 293 
healthy control cartilage (p=0.085) whereas the filling of the chondral samples differed from 294 
the controls (p<0.001). 295 
More than half of the osteochondral lesions in each diameter category showed repair tissue 296 
with good Safranin-O stain uptake whereas only one of the chondral lesions showed Safranin-297 
O positive tissue at the repair site (Table 2). As the repair tissue was absent from two 4 mm 298 
chondral lesion and four 8 mm chondral lesion samples, those samples were perceived 299 
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negative for Safranin-O uptake. Typically, the osteochondral samples showed hyaline-like 300 
cartilage in the deep or middle part of the repair tissue and fibrous tissue on the surface. The 301 
best and the worst repairs in each group are shown in Figure 8.  302 
Typically, osteochondral defects showed lower values of OARSI score than chondral defects 303 
(Table 1). This is indicative of better tissue quality in the osteochondral samples. Loss of 304 
Safranin-O uptake was common in all of the defect sizes. No degenerative changes were 305 
detected in the control cartilage adjacent to the lesions.  306 
Immunohistochemistry 307 
Almost all of the 2 mm osteochondral samples (4 of 5) showed positive type II collagen 308 
staining and only one of these samples showed positive type I collagen staining (Figure 7, 309 
Table 2).  In the 2 mm chondral samples, positive staining for type II and type I collagen was 310 
shown in 1 of 5 and 4 of 5 samples, respectively. Fibrocartilage formation was evident in the 311 
larger chondral and osteochondral lesions where a mixture of type I and type II collagen 312 
positive tissue was present. Since the repair tissue was detached from two of the 4 mm 313 
chondral lesions and four of the 8 mm chondral lesions, these were perceived negative for 314 
both type I and II collagen.   315 
 316 
Discussion 317 
The purpose of this study was to determine the intrinsic repair capacity of equine carpal 318 
articular cartilage to set a benchmark for studies evaluating articular cartilage repair strategies 319 
using the equine carpus as a model. Knowledge on spontaneous repair capacity and critical 320 
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lesion size improves cost-effectiveness and minimizes animal suffering in animal 321 
experiments. The quality and quantity of the repair tissue in both chondral and osteochondral 322 
defects were evaluated in this study. Complete tissue regeneration was not achieved as the 323 
repair tissue structure differed from healthy cartilage in all the defects. Only the osteochondral 324 
lesions with 2 mm diameter showed good Safranin-O staining indicating a good quality of the 325 
repair tissue, while equally sized chondral defects failed to spontaneously repair to hyaline 326 
cartilage. Chondral defects and osteochondral defects with the diameter of 4 mm and 8 mm 327 
showed depletion of proteoglycans and structural disorganization.  328 
The healing of equine carpal cartilage defects was first described by Riddle (17) who created 329 
superficial and full-thickness defects in the carpus of four horses (150 mm2) and six ponies 330 
(100 mm2). He concluded that the superficial defects did not heal past the 8-month time point 331 
and that in order for the defects to heal, they should reach the subchondral bone. The 332 
importance of the connection to the bone marrow spaces has since been confirmed by others. 333 
(18,19) Mean filling of both untreated and microfracture-treated chondral defects of 100 mm2 334 
in equine carpus in the study by Frisbie was, however, only 65% or less. (18) 335 
In a study evaluating spontaneous healing of full-thickness cartilage defects in the equine 336 
carpus by Hurtig et al., (5) lesions with a surface area of 5 mm2 were filled with 337 
fibrocartilaginous repair tissue but lesions of 15 mm2 deteriorated to dense fibrous tissue. This 338 
is corroborated by our study, where nearly all full-thickness chondral defects of 3 mm2 (2 mm 339 
in diameter) showed fibrocartilaginous repair, and larger defects presented with incomplete 340 
fibrocartilage covering or no repair tissue at all.  341 
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Spontaneous defect healing reported in previous equine studies is mainly described as filling 342 
of the lesions or formation of fibrous tissue and fibrocartilage. (5,20) Fibrocartilage, however, 343 
has lower mechanical strength than hyaline cartilage and as such, it is more prone to wearing 344 
out. (21) Durable, long-lasting results can only be achieved by restoration of fully functional 345 
hyaline cartilage. (6) The focus of interventions aiming at cartilage repair has shifted from 346 
simply filling the lesions to restoring mature hyaline cartilage. In order to reliably determine 347 
the critical lesion size, it is paramount to evaluate both the quantity and quality of repair 348 
tissue. In the present study, only the osteochondral defects showed hyaline-like repair tissue 349 
with higher proteoglycan content and better filling after a 12-month follow-up (Figure 4, 350 
Figure 8). Even though small full-thickness chondral defects have been thought to heal 351 
spontaneously (3,5,8), the results of this study suggest otherwise. Although the filling in the 2 352 
mm defects was good macroscopically, depletion of proteoglycans was evident both in 353 
Safranin-O staining and gadolinium-enhanced MR imaging (T1Gd). Structural disorganization 354 
and fibrocartilage formation were seen in polarized light microscopy and as a mixture of type 355 
I and II collagen staining in immunohistochemistry, and low T2 and T1Gd values in MRI. 356 
(22,23)  The deep part of the repair tissue in the osteochondral defects showed a structure 357 
closely resembling that of the healthy control tissue in polarized light microscopy, whereas 358 
the chondral defects showed poorly organized tissue in each layer, implying a mechanically 359 
weaker tissue structure. These findings substantiate the previous studies that show that the 360 
repair tissue originates from the bone marrow (24) and explain the poor outcome of the 361 
chondral defects. 362 
Although the osteochondral defects showed better repair than chondral defects, the bone voids 363 
of the deep osteochondral defects did not heal or even became larger, extending up to 9 mm 364 
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into the bone, during the 12-month follow-up. Even the smallest 2 mm osteochondral lesions 365 
showed bone pathologies at the time of the post mortem analysis (4 of 5 specimens). Frequent 366 
cyst formation after a disruption of subchondral bone has been reported in previous equine 367 
studies. (18,25) The present study makes no exception: chondral lesions presented with no 368 
cysts whereas bone defects were detected in osteochondral lesions of all sizes (2, 4 and 8 369 
mm). 370 
The long-term follow-up time of 12 months in this study gives a better understanding of the 371 
spontaneous repair capacity of equine carpal joint cartilage than the shorter time periods of 372 
previous studies on spontaneous repair. (8,26) Additionally, this study has several 373 
methodological benefits, as current state-of-art methods were used in assessing the repair 374 
tissue quality. The tissue was evaluated prior to any processing macroscopically and with 375 
µCT and MRI. The outcome of polarized light microscopy reflects the mechanical strength of 376 
the repair tissue. (27,28) Finally, the overall quality of the repair tissue was assessed with 377 
histological and immunohistochemical techniques. The findings of different methods support 378 
each other.  379 
There were some limitations in this study. Since defects were created in different sites of the 380 
joint, they were subjected to different weight-bearing conditions. (7,8) All defects with the 381 
same diameter were, however, located on the same site and thus the comparison between 382 
chondral and osteochondral defects is justified. The third carpal bone, where the 4 mm and 8 383 
mm defects were located, bears most weight and is the site in the equine carpus that is most 384 
frequently affected by cartilage pathologies. (29) Nonetheless, not even the 2 mm lesions 385 
located on the less weight-bearing second carpal bone healed well.  386 
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Altogether four defects were created in the middle carpal joint of the horses. The combined 387 
area of these defects was 94 mm2, which might possibly have affected the repair of the 388 
individual lesions, although degenerative changes were absent around the lesions or on the 389 
articulating surfaces. Further, it is not uncommon to create more defects per joint when using 390 
the equine model (30,31). In our study in the carpus, none of the lesions with a diameter of 4 391 
mm (13 mm2) or 8 mm (50 mm2) healed with mature hyaline cartilage. Even the smallest 2 392 
mm in diameter (3 mm2) lesions, which were initially thought to serve as the control lesions 393 
with good spontaneous healing showed repair tissue of questionable quality at 12 months.  394 
 395 
Conclusion 396 
The horse is a good animal model for cartilage research and, like humans, it has a very limited 397 
spontaneous healing capacity. Based on this study, we recommend using 4 mm diameter as 398 
the critical size for osteochondral lesions and 2 mm diameter lesion as the critical size for 399 
chondral lesions in articular cartilage repair research using the equine carpal joint model. 400 
  401 
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Figure legends 500 
Figure 1. Schematic drawing of the left equine carpal bones II-IV with the four different 501 
lesion sizes marked with dashed lines.   502 
Figure 2. Representative MRI relaxation time maps of the chondral (top row) and 503 
osteochondral (bottom row) lesions of 2 mm diameter. Lesion site is immediately below the 504 
scale bar (2 mm). Shorter T1Gd relaxation times were observed in both lesions, but more 505 
prominently so in the chondral lesion (a). Slight differences as compared to the adjacent tissue 506 
were also evident in the T2 and T1 relaxation time maps (a, b). The ROI for control tissue is 507 
exemplified in the magnification of b.  In the magnification of c, the ROI 1 for the repair 508 
tissue is marked with red, and the ROI 2 aligned to adjacent healthy cartilage is marked with 509 
green. 510 
Figure 3. Photographs of the joints taken directly after sacrificing the animals. Chondral 511 
lesions are in the left column and osteochondral in the right column. Each horse is represented 512 
in its own row. Macroscopically, 5 of 5 osteochondral and 3 of 5 chondral lesions with the 513 
diameter of 2 mm were filled with repair tissue. Of the 4 mm lesions, only one chondral 514 
lesion (horse D) was well filled, the other lesions were easily distinguishable and not filled to 515 
the level of the surrounding cartilage. Each 8 mm defect was clearly visible but one 516 
osteochondral defect (horse E) showed good filling in the middle of the lesion. 517 
Figure 4. Micro-computational tomographic image of the middle part of each specimen. The 518 
osteochondral lesions (b, d, f) presented with subchondral bone resorption, whereas the bone 519 
structure in the chondral lesions (a, c, e) was either undisturbed or slightly decreased in 520 
density. Arrowheads show the site of the original defect.  521 
Figure 5. Mean relaxation time values (ms) of the magnetic resonance imaging in the different 522 
cartilage ROIs. Results for the repair tissue only (ROI 1) in each group are shown in (a), and 523 
the area aligned to the adjacent healthy cartilage (ROI 2) was divided into a superficial half 524 
(b) and deep half (c). Chondral lesions are colored white and osteochondral ones dark gray. 525 
The whiskers represent 95% confidence interval. Statistically significant p values are marked 526 
in the images.  527 
Figure 6. Bar diagrams showing the mean parallelism index (PI, top row) of the collagen 528 
fibrils and the mean orientation (bottom row) of the fibrils. Chondral lesions are colored white 529 
and osteochondral lesions dark gray. The whiskers represent 95% confidence interval. 530 
Statistically significant p values are marked in the images.  531 
Figure 7. Representative osteochondral defect with a diameter of 2 mm. a) Polarized light 532 
microscopy showed the change in collagen orientation toward the typical tangential 533 
orientation in the superficial layer. b) Safranin-O staining showed good filling and abundant 534 
proteoglycans in the deep part of the repaired cartilage tissue. c) Immunohistochemical 535 
staining for type II collagen. Scale bar: 500 µm. 536 
Figure 8. The best and worst Safranin-O stained histological section in each study group. 537 
Repair tissue seemed to originate partly from the subchondral bone at the sites where the 538 
calcified cartilage was disrupted (arrows). Scale bars: 1 mm.  539 
